Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1987-07-28
1989-04-25
Rosen, Sam
Drug, bio-affecting and body treating compositions
Lymphokine
435236, 4351721, 935 65, A61K 3912
Patent
active
048246670
ABSTRACT:
Bovine herpesvirus type 1 (infectious bovine rhinotracheitis virus) mutants which fail to produce any functional thymidine kinase as a result of a deletion in the thymidine kinase gene. The deletion in the thymidine kinase gene attenuates the viruses so that they can be used as an active agent in a modified live-virus vaccine against infectious bovine rhinotracheitis. This invention also relates to methods for the production and use of the same.
REFERENCES:
patent: 3634587 (1972-01-01), Ament et al.
patent: 3925544 (1975-12-01), Shechmeister et al.
patent: 4291019 (1981-09-01), Lupton et al.
patent: 4514497 (1985-04-01), Kit et al.
patent: 4569840 (1986-02-01), Kit
Mayfield et al, J. Virol., 47(1):259-264 (1983).
Post et al, Cell, 25:227-232 (1981).
Smiley, Nature, 385:333-335 (1980).
McDermott et al, J. Virol., 51(3):747-753 (1983).
Post et al, Cell, 24:555-565 (1981).
Pritchett et al, Am. J. Vet. Res., 45(12):2486-2489 (1984).
Kit et al, Virol., vol. 130, pp. 381-389 (1983).
Qavi et al, Abst. Annu. Meet Am. Soc. Microbiol. 83, "Isolation of Thymidine Kinase Negative Infectious Bovine Rhinotracheitis Virus Mutants", 1983.
Kit Malon
Kit Saul
Baylor College of Medicine
Novagene Inc.
Rosen Sam
LandOfFree
Thymidine kinase deletion mutants of bovine herpesvirus-1, vacci does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thymidine kinase deletion mutants of bovine herpesvirus-1, vacci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thymidine kinase deletion mutants of bovine herpesvirus-1, vacci will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1194857